ELV
Elevance Health, Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$422.02
+1.84%0
Insider buys (3m)
13
Insider sells (3m)
-$4.7M
Net value (3m)
+11.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 400 | $434 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 273 | $447 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 827 | $446 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 440 | $444 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 240 | $438 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 1,160 | $439 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 321 | $435 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 480 | $443 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 160 | $445 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 1,720 | $440 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 560 | $437 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 1,660 | $436 |
| Oct 23, 2026 | Kaye Mark · officer: EVP & CFO | Sale | 2,343 | $441 |
| Oct 6, 2026 | Kaye Mark · officer: EVP & CFO | F-InKind | 4,161 | $386 |
| Oct 6, 2026 | Kaye Mark · officer: EVP & CFO | A-Award | 2,627 | $0.00 |
| Sep 4, 2026 | Wessling Erin M · officer: EVP & Chief Legal Officer | F-InKind | 94 | $406 |
| Sep 4, 2026 | Wessling Erin M · officer: EVP & Chief Legal Officer | F-InKind | 255 | $415 |
| Sep 4, 2026 | Craig Ryan R · officer: EVP & Chief HR Officer | F-InKind | 144 | $406 |
| Jul 17, 2026 | PERU RAMIRO G · director | Purchase | 1,000 | $366 |
| Jul 17, 2026 | BOUDREAUX GAIL · director, officer: President and CEO | Purchase | 2,045 | $368 |
| Jul 17, 2026 | BOUDREAUX GAIL · director, officer: President and CEO | Purchase | 680 | $366 |
| Jun 15, 2026 | Penczek Ronald W · officer: CAO & Controller | Sale | 369 | $403 |
| Jun 12, 2026 | Dixon Robert L JR · director | Sale | 151 | $402 |
| May 20, 2026 | Penczek Ronald W · officer: CAO & Controller | M-Exempt | 654 | $271 |
| May 20, 2026 | Penczek Ronald W · officer: CAO & Controller | M-Exempt | 877 | $311 |
| May 20, 2026 | Penczek Ronald W · officer: CAO & Controller | Sale | 1,531 | $403 |
| May 15, 2026 | Jallal Bahija · director | A-Award | 563 | $0.00 |
| May 15, 2026 | HAY LEWIS III · director | A-Award | 563 | $0.00 |
| May 15, 2026 | STRABLE-SOETHOUT DEANNA D · director | A-Award | 563 | $0.00 |
| May 15, 2026 | SCHULMAN AMY W · director | A-Award | 563 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 427Increased 1099Reduced 1215Sold out 117
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 19,887,111 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 18,991,090 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 14,345,459 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 14,058,204 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 10,426,610 | Sep 22, 2026 |
| STATE STREET CORP | Reduced | 10,288,696 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 9,213,513 | Aug 14, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 8,228,537 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 6,356,077 | May 8, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 6,214,356 | Aug 13, 2026 |
| SANDERS CAPITAL, LLC | Increased | 5,894,303 | May 14, 2026 |
| Sanders Capital, LLC | Reduced | 5,825,024 | Aug 10, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 5,192,707 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 5,166,124 | Aug 12, 2026 |
| HARRIS ASSOCIATES L P | Increased | 5,136,526 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 23, 2026